Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248218438> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4248218438 endingPage "651" @default.
- W4248218438 startingPage "644" @default.
- W4248218438 abstract "This multicentre, randomized study was performed to assess the efficacy and safety of 0.25 mg ganirelix (Orgalutran, Antagon) treatment, using triptorelin (Decapeptyl) in a long protocol as a reference treatment. In total, 236 subjects were randomized to treatment with ganirelix (0.25 mg, s.c.) and 119 to triptorelin (0.1 mg, s.c.) treatment (treatment ratio 2:1). Treatment with ganirelix started on day 6 of stimulation, whereas treatment with triptorelin started on menstrual cycle day 21 to 24 of the previous cycle (i.e. the midluteal phase). The ganirelix regimen was on average 17 days shorter (9 versus 26 days) compared to the triptorelin regimen. The median total dose of recombinant FSH (Puregon) used was 450 IU less (1350 versus 1800 IU) in the ganirelix protocol. The initial follicular growth was faster and, consequently, oestradiol concentrations were higher in the ganirelix group. On the day of human chorionic gonadotrophin (HCG), the mean number of follicles > or = 11 mm was 10.1 and 10.7 and the median serum oestradiol concentration was 1090 and 1370 pg/ml in the ganirelix and triptorelin groups respectively. Per attempt, 7.9 and 9.6 oocytes (mean) were retrieved in the ganirelix and triptorelin groups respectively. The fertilization rates (64.0% ganirelix and 64.9% triptorelin) and the mean number of good quality embryos (2.7 and 2.9) were comparable in both treatment groups. The implantation rate was identical (22.9%). The ongoing pregnancy rate per attempt was 31.0 and 33.9% in the ganirelix and triptorelin groups respectively. The ganirelix regimen showed an improved local tolerance in that the percentage of subjects with at least one local skin reaction was 2-fold lower than in the triptorelin group (11.9 versus 24.1%). Taking all data together, it may be concluded that ganirelix offers a new treatment regimen in ovarian stimulation that is short, safe and well-tolerated, optimizing convenience for the patient." @default.
- W4248218438 created "2022-05-12" @default.
- W4248218438 date "2001-04-01" @default.
- W4248218438 modified "2023-10-17" @default.
- W4248218438 title "Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation" @default.
- W4248218438 cites W1758516527 @default.
- W4248218438 cites W1860011699 @default.
- W4248218438 cites W2116379157 @default.
- W4248218438 cites W2117170250 @default.
- W4248218438 cites W2131053749 @default.
- W4248218438 cites W2155645913 @default.
- W4248218438 cites W2405710866 @default.
- W4248218438 cites W2475911902 @default.
- W4248218438 doi "https://doi.org/10.1093/humrep/16.4.644" @default.
- W4248218438 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11278211" @default.
- W4248218438 hasPublicationYear "2001" @default.
- W4248218438 type Work @default.
- W4248218438 citedByCount "191" @default.
- W4248218438 countsByYear W42482184382012 @default.
- W4248218438 countsByYear W42482184382013 @default.
- W4248218438 countsByYear W42482184382014 @default.
- W4248218438 countsByYear W42482184382015 @default.
- W4248218438 countsByYear W42482184382016 @default.
- W4248218438 countsByYear W42482184382017 @default.
- W4248218438 countsByYear W42482184382018 @default.
- W4248218438 countsByYear W42482184382019 @default.
- W4248218438 countsByYear W42482184382020 @default.
- W4248218438 countsByYear W42482184382021 @default.
- W4248218438 countsByYear W42482184382022 @default.
- W4248218438 countsByYear W42482184382023 @default.
- W4248218438 crossrefType "journal-article" @default.
- W4248218438 hasBestOaLocation W42482184381 @default.
- W4248218438 hasConcept C126322002 @default.
- W4248218438 hasConcept C134018914 @default.
- W4248218438 hasConcept C2776537878 @default.
- W4248218438 hasConcept C2778575703 @default.
- W4248218438 hasConcept C2778894405 @default.
- W4248218438 hasConcept C2779234561 @default.
- W4248218438 hasConcept C2779448150 @default.
- W4248218438 hasConcept C2781413609 @default.
- W4248218438 hasConcept C29456083 @default.
- W4248218438 hasConcept C54355233 @default.
- W4248218438 hasConcept C71315377 @default.
- W4248218438 hasConcept C71924100 @default.
- W4248218438 hasConcept C86803240 @default.
- W4248218438 hasConceptScore W4248218438C126322002 @default.
- W4248218438 hasConceptScore W4248218438C134018914 @default.
- W4248218438 hasConceptScore W4248218438C2776537878 @default.
- W4248218438 hasConceptScore W4248218438C2778575703 @default.
- W4248218438 hasConceptScore W4248218438C2778894405 @default.
- W4248218438 hasConceptScore W4248218438C2779234561 @default.
- W4248218438 hasConceptScore W4248218438C2779448150 @default.
- W4248218438 hasConceptScore W4248218438C2781413609 @default.
- W4248218438 hasConceptScore W4248218438C29456083 @default.
- W4248218438 hasConceptScore W4248218438C54355233 @default.
- W4248218438 hasConceptScore W4248218438C71315377 @default.
- W4248218438 hasConceptScore W4248218438C71924100 @default.
- W4248218438 hasConceptScore W4248218438C86803240 @default.
- W4248218438 hasIssue "4" @default.
- W4248218438 hasLocation W42482184381 @default.
- W4248218438 hasLocation W42482184382 @default.
- W4248218438 hasOpenAccess W4248218438 @default.
- W4248218438 hasPrimaryLocation W42482184381 @default.
- W4248218438 hasRelatedWork W1966504330 @default.
- W4248218438 hasRelatedWork W1979139803 @default.
- W4248218438 hasRelatedWork W1998506244 @default.
- W4248218438 hasRelatedWork W2048183571 @default.
- W4248218438 hasRelatedWork W2071299556 @default.
- W4248218438 hasRelatedWork W2099049428 @default.
- W4248218438 hasRelatedWork W2132342248 @default.
- W4248218438 hasRelatedWork W2145363038 @default.
- W4248218438 hasRelatedWork W2748952813 @default.
- W4248218438 hasRelatedWork W3028803890 @default.
- W4248218438 hasVolume "16" @default.
- W4248218438 isParatext "false" @default.
- W4248218438 isRetracted "false" @default.
- W4248218438 workType "article" @default.